What are the dosing parameters for clonidine (antihypertensive medication)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clonidine Dosing Parameters for Hypertension

For antihypertensive therapy, start clonidine at 0.1 mg twice daily (morning and bedtime), with weekly increments of 0.1 mg/day as needed, targeting a typical maintenance range of 0.2-0.6 mg/day in divided doses. 1

Initial Dosing

  • Begin with 0.1 mg twice daily (morning and bedtime administration) 1
  • Elderly patients should receive a lower initial dose due to increased risk of CNS side effects 1, 2
  • Patients with renal impairment require a lower starting dose with careful monitoring 1

Dose Titration

  • Increase by 0.1 mg per day at weekly intervals until desired blood pressure response is achieved 1
  • Taking the larger portion of the daily dose at bedtime minimizes transient side effects of dry mouth and drowsiness 1
  • Dividing doses into twice-daily administration maintains steady blood levels 2

Maintenance Dosing

  • Therapeutic range: 0.2-0.6 mg/day in divided doses (most commonly employed) 1
  • Maximum effective daily dose is 2.4 mg, though doses this high are rarely used 1
  • Steady-state plasma concentrations are typically reached by day 4 of therapy 3

Hypertensive Urgencies/Emergencies (Rapid Titration Protocol)

  • Initial dose: 0.1-0.2 mg orally 4
  • Follow with 0.05-0.1 mg hourly until goal blood pressure achieved or maximum total dose of 0.7-0.8 mg given 5, 4
  • This achieves significant blood pressure reduction in 93% of patients 4
  • Mean response time is approximately 1.8 hours with mean effective dose of 0.32 mg 5

Alternative Formulations

  • Transdermal patches deliver 0.1-0.3 mg weekly, with maximum blood pressure reduction occurring 2-3 days after initial application and maintained for 7 days 3
  • Intramuscular administration (150 mcg) produces effect within 5 minutes, maximal at 75 minutes, persisting 5 hours—useful when oral therapy cannot be tolerated 6

Critical Safety Considerations

  • Never abruptly discontinue clonidine—must be tapered to avoid rebound hypertensive crisis 2, 7, 1
  • Monitor blood pressure regularly throughout therapy 2
  • Common side effects include dry mouth, drowsiness, dizziness, and sedation, which correlate significantly with plasma concentrations 8, 2
  • Peak plasma concentration occurs approximately 2 hours after oral administration with elimination half-life of 7.5-7.7 hours 8

Special Populations

  • Renal impairment: Lower initial doses required; hemodialysis does not significantly remove clonidine, so no supplemental dosing needed post-dialysis 1
  • Elderly: Start with lower doses due to increased CNS adverse effects 1, 2
  • Pregnancy: Use only after careful risk-benefit assessment 2

Pharmacokinetic Considerations

  • Absorption half-life: 0.6 hours 8
  • Elimination half-life: 7.5-7.7 hours 8
  • Approximately one-third of administered dose excreted unchanged in urine within 24 hours 8
  • Plasma concentration varies considerably between individuals due to interindividual variation in renal clearance 3

References

Guideline

Clonidine Dosing for Hyperhidrosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical pharmacokinetics of clonidine.

Clinical pharmacokinetics, 1988

Research

The use of clonidine by intramuscular injection in the treatment of hypertension.

Australian and New Zealand journal of medicine, 1977

Guideline

Clonidine Dosage and Administration for Anxiety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacokinetics and side-effects of clonidine.

European journal of clinical pharmacology, 1978

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.